home

FATE.US | summary | financial summary | prediction chart | global stock news | news graph | volatility | components |pairs | earnings | dividends | sales | compare

symbollastchange%chngnamemcapsectorwiki
FATE
US
Fate Therapeutics Inc

Market global news for FATE (US) Fate Therapeutics Inc

Global news - US chevrons indicate local prediction, arrows show global predictions
Today
previous days
Fate Therapeutics, Inc. (NASDAQ:FATE) Sees Significant Growth in Short Interest
wkrb13 - 00:00 Tue 16 - FATE - link story
Fate Therapeutics (NASDAQ:FATE) Stock Rating Reaffirmed by Needham & Company LLC
tickerreport - 11:00 Fri 12 - FATE - link story
Fate Therapeutics (NASDAQ:FATE) Shares Gap Down to $6.76
tickerreport - 16:15 Wed 10 - FATE - link story
Fate Therapeutics (NASDAQ:FATE) Shares Gap Down to $6.76
dailypolitical - 16:15 Wed 10 - FATE - link story
Century Therapeutics Presents New Preclinical Data Highlighting Ipsc-Derived Cell Therapy Platform Technology At The 2024 American Association For Can...
menafn - 21:45 Mon 8 - FATE - link story
Century Therapeutics Presents New Preclinical Data Highlighting iPSC-derived Cell Therapy Platform Technology at the 2024 American Association for Cancer Research (AACR) Annual Meeting
tmcnet - 21:00 Mon 8 - FATE - link story
Century Therapeutics Presents New Preclinical Data Highlighting iPSC-derived Cell Therapy Platform Technology at the 2024 American Association for Cancer Research (AACR) Annual Meeting
marketscreener - 20:30 Mon 8 - FATE - link story
Fate Therapeutics, Inc. (NASDAQ:FATE) Receives Average Recommendation of "Hold" from Analysts
themarketsdaily - 09:30 Thu 4 - FATE - link story
Fate Therapeutics to Present at 23rd Annual Needham Virtual Healthcare Conference
eagletribune - 17:30 Wed 3 - FATE - link story
Fate Therapeutics to Present at 23rd Annual Needham Virtual Healthcare Conference
marketscreener - 12:15 Wed 3 - FATE - link story
Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
eagletribune - 21:15 Tue 2 - FATE - link story
ADARx Pharmaceuticals Appoints Dr. Chris Storgard as Chief Medical Officer
tmcnet - 15:15 Tue 2 - FATE - link story
Fate Therapeutics (NASDAQ:FATE) Price Target Raised to $6.00
theenterpriseleader - 07:30 Mon 1 - FATE - link story
Fate Therapeutics (NASDAQ:FATE) versus Kiromic BioPharma (NASDAQ:KRBP) Head-To-Head Comparison
defenseworld net - 06:30 Tue 26 - FATE - link story
Fate Therapeutics (NASDAQ:FATE) Shares Up 5.1%
tickerreport - 22:00 Mon 25 - FATE - link story
Fate Therapeutics (NASDAQ:FATE) Trading 5.1% Higher
dailypolitical - 22:00 Mon 25 - FATE - link story
HC Wainwright Reaffirms "Neutral" Rating for Fate Therapeutics (NASDAQ:FATE)
themarketsdaily - 08:30 Sat 23 - FATE - link story
Fate Therapeutics Announces Pricing Of $100 Million Underwritten Offering And Concurrent Private Placement
menafn - 15:30 Tue 19 - FATE - link story
Fate Therapeutics Announces Pricing of $100 Million Underwritten Offering and Concurrent Private Placement
wallstreet-online de - 14:45 Tue 19 - FATE - link story
Fate Therapeutics (FATE) Prices 14.55M Share Offering at $5.50/sh
streetinsider - 13:30 Tue 19 - FATE - link story
Fate Therapeutics Announces Pricing of $100 Million Underwritten Offering and Concurrent Private Placement
tmcnet - 13:15 Tue 19 - FATE - link story
Fate Therapeutics Announces Pricing of $100 Million Underwritten Offering and Concurrent Private Placement
marketscreener - 13:00 Tue 19 - FATE - link story
Fate Therapeutics (NASDAQ:FATE) Stock Price Up 4.7%
wkrb13 - 18:45 Fri 15 - FATE - link story
Fate Therapeutics (NASDAQ:FATE) Stock Price Up 4.7%
tickerreport - 18:45 Fri 15 - FATE - link story